logo

CTMX

CytomX Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
5.38 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy CTMX Now?
  • Based on a composite score of 5.38/10, we rate CTMX as a Netural. Our analysis breaks down into 3.98/10 for Fundamentals, 6.05/10 for Technicals, and 5.75/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is CTMX fundamentally strong?
What is the current technical signals for CTMX?
What is the market sentiment for CTMX?